The Surgical Company has acquired Hospithera to enhance its market position in Belgium and expand its portfolio of medical devices and supplies.

Information on the Target

The Surgical Company, based in Amersfoort, the Netherlands, operates through two primary divisions: one focusing on the distribution of innovative medical devices and supplies, and the other on the development, production, and marketing of proprietary advanced technological products for hospitals. Its distribution division boasts a solid presence across France, Belgium, the Netherlands, and Germany, specializing in the introduction of cutting-edge medical technologies in various fields, including anaesthesia, pulmonology, interventional and general surgery, cardiology, radiology, neonatology, and uro- and gynaecology. The overall consolidated revenues of The Surgical Company exceed €75 million.

The recent acquisition of Hospithera marks a significant enhancement of The Surgical Company's market position in Belgium. By integrating Hospithera, which has established itself as a leading supplier of medical devices and supplies, The Surgical Company aims to consolidate its services in the region while continuing to support local brands like Sebac and Adhesia in France. This strategic move underscores their commitment to local branding while expanding their operational footprint in the healthcare sector.

Industry Overview in Belgium

The Belgian healthcare market is recognized for its high level of medical innovation and quality of care. With a robust reimbursement framework, Belgium has become an attractive environment for both local and international medical device companies. The landscape is cha